Brief: Autolus Therapeutics Reports Third Quarter 2022 Financial Results
03/11/2022 11:33
Nov 3 (Reuters) - Autolus Therapeutics Plc AUTL.O :
* AUTOLUS THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
* COMMERCIAL MANUFACTURING SITE BUILD ON SCHEDULE FOR
HANDOVER OF
FIRST CLEAN ROOMS TO AUTOLUS IN Q4 2022
* QTRLY LOSS PER SHARE $0.47
* Q3 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA
* AUTOLUS THERAPEUTICS-ESTIMATES CURRENT CASH ON HAND &
ANTICIPATED MILESTONE PAYMENTS IN RELEVANT PERIOD FROM
BLACKSTONE EXTENDS CO'S RUNWAY INTO 2024
Source text for Eikon: ID:nGNX25gfTw
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants